Positive phase 3 results from the CAN-2409 clinical trial in intermediate-to-high risk localized prostate cancer have been ...

The following selected financial data is summarized from the Company's consolidated financial statements and related notes thereto (the "Financial Statements”) for the three months ended March 31, ...

With the end of the school year right around the corner, many parents are finding themselves exhausted. Here are some tips for getting over the finish line from ReMerge CEO Erin Engelke.